Terminal ileum resection is associated with increased risk for colorectal cancer among individuals with Crohn disease.

HealthDay News — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

Complete endoscopic healing among individuals with Crohn disease is associated with better long-term outcomes.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Adding atezolizumab and bevacizumab to TACE can improve outcomes in previously untreated, unresectable HCC, data suggest.